Recombinant human follicle-stimulating hormone and human chorionic gonadotropin for induction of spermatogenesis in a hypogonadotropic male.
OBJECTIVE
To determine the efficacy of recombinant FSH administration to induce spermatogenesis.


METHODS
Case report, clinical study.


METHODS
Tertiary center for reproductive medicine of the university.


METHODS
A 44-year-old hypogonadal man with postpubertal pituitary insufficiency due to surgical removal of a prolactinoma.


METHODS
Recombinant FSH (150 IU three times weekly) was administered together with hCG (1,500 IU twice weekly). Control examinations were performed every 6 weeks, including hormone determinations, safety parameters, testicular volume measurements, and semen analysis.


METHODS
Semen parameters.


RESULTS
After 18 weeks of treatment, first sperm were seen in the ejaculate and reached normal sperm concentrations after 24 weeks of treatment. Serum hormone levels were in the normal range and testicular volume increased. No adverse side effects were observed.


CONCLUSIONS
Recombinant human FSH in combination with hCG can be used successfully for stimulation of testicular function in gonadotropin-deficient men.
Kliesch
S
S
Institute of Reproductive Medicine of the University, Münster, Germany.
Behre
H M
HM
Nieschlag
E
E
D000328:Adult; D006063:Chorionic Gonadotropin / Q000008:administration & dosage / Q000627:therapeutic use*; D005640:Follicle Stimulating Hormone / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007006:Hypogonadism / Q000188:drug therapy*; D008297:Male; D011994:Recombinant Proteins / Q000627:therapeutic use; D013076:Sperm Count; D013081:Sperm Motility; D013091:Spermatogenesis
D006063:Chorionic Gonadotropin; D011994:Recombinant Proteins; D005640:Follicle Stimulating Hormone